ストックスクリーナーアプリを入手
27.51
1.40%
-0.39
アフターアワーズ：
27.51
Immunovant Inc (IMVT) 最新ニュース
Immunovant chief legal officer Van Tuyl sells $42,543 in stock By Investing.com - Investing.com South Africa
Immunovant chief legal officer Van Tuyl sells $42,543 in stock By Investing.com - Investing.com Canada
Immunovant COO Melanie Gloria sells shares worth $71,846 By Investing.com - Investing.com South Africa
Form 4 Immunovant Inc For: 9 October By Investing.com - Investing.com South Africa
Form 4 Immunovant Inc For: 9 October - Investing.com India
Immunovant COO Melanie Gloria sells shares worth $71,846 - Investing.com India
Immunovant CEO Eric Venker sells $119,589 in shares By Investing.com - Investing.com Nigeria
Form 4 Immunovant Inc For: 5 October By Investing.com - Investing.com South Africa
Immunovant CEO Eric Venker sells $119,589 in shares By Investing.com - Investing.com Canada
Form 4 Immunovant Inc For: 5 October By Investing.com - Investing.com Canada
Form 4 Immunovant Inc For: 5 October By Investing.com - Investing.com UK
Immunovant CLO Christopher Van Tuyl Executes Mandatory Sale of 2,846 Shares for Tax Withholding - Kalkine Media
How (IMVT) Movements Inform Risk Allocation Models - Stock Traders Daily
Immunovant Announces Voting Outcomes from 2026 Annual Stockholders Meeting - Kalkine Media
Immunovant (IMVT) Slips 0.94% to $39.12 as Shares Test Resistance at $41.08OBV Breakout - vinanet.vn
Roivant Sciences (ROIV) president sells 200,000 shares under preset plan - Stock Titan
Why (IMVT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Roivant (NASDAQ: ROIV) president settles RSU taxes in shares - Stock Titan
Immunovant's Risk/Reward Profile Balanced After Recent Rally, UBS Says - marketscreener.com
Immunovant (IMVT) Watch: Stays Close to Unchanged at $44.37; Technical Setup: Support at $42.15 and Resistance at $46.59 Frame the Range at the CloseBear Flag - vinanet.vn
Immunovant (IMVT) Watch: Stays Close to Unchanged at $44.37; Technical Setup: Support at $42.15 and Resistance at $46.59 Frame the Range at the CloseStraddle Setup - dars.gov.et
Deep Track Capital, LP Trims Immunovant Inc (IMVT) Stake in Stra - GuruFocus
Immunovant Inc GLP-1 Receptor Agonists Weight Management Diabetes Treatments *79wfgdDXy* - Villa de la Orotava
immunovant inc glp 1 receptor agonist diabetes weight managementView IiKNF3uia - Villa de la Orotava
Immunovant (IMVT) Results at a Glance: The Available Earnings Metric Delivers a Miss under the Current Snapshot; Post-Earnings: Shares Move Lower 1.98% in the Available RecordAnalyst Consensus Shift - vinanet.vn
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm - Morningstar
Immunovant Inc GLP-1 Receptor Agonists Weight Management Diabetes Treatments *BI2Y6DHdO* - scchr.jp
Investigation launched into Immunovant officers for possible self-dealing harming shareholders - Pluang
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm - PR Newswire
Immunovant (IMVT) Stock: Moves 1.49% Up to $44.96 in Latest Trading; Immediate View: Support at $42.71 and Resistance at $47.21 Frame the Range in the Latest ReadingPassive Flow - vinanet.vn
Immunovant (IMVT) Stock: Moves 1.49% Up to $44.96 in Latest Trading; Immediate View: Support at $42.71 and Resistance at $47.21 Frame the Range in the Latest ReadingSign of Strength - dars.gov.et
Immunovant (IMVT) Holds Steady at $41.82: Consolidation Between Key Support and ResistanceThematic ETF Flow - vinanet.vn
GSA Capital Partners LLP Takes $2.52 Million Position in Immunovant, Inc. $IMVT - MarketBeat
Assenagon Asset Management S.A. Has $639,000 Holdings in Immunovant, Inc. $IMVT - MarketBeat
Immunovant (IMVT) Holds Steady at $41.82 as Shares Consolidate in a Tight RangeGamma Exposure - vinanet.vn
Dimensional Fund Advisors LP Sells 103,356 Shares of Immunovant, Inc. $IMVT - MarketBeat
Why Immunovant (IMVT) Is Up 5.2% After Wider Q1 Loss, Moderna Cash, And Pivotal Data Hype - simplywall.st
Why Immunovant (IMVT) Is Up 5.2% After Wider Q1 Loss, Moderna Cash, And Pivotal Data Hype - simplywall.st
Immunovant (IMVT) Q1 2027 Earnings Call Transcript - AOL.com
Immunovant (NASDAQ:IMVT) Reaches New 12-Month HighShould You Buy? - MarketBeat
Immunovant stock hits 52-week high at 41.37 USD By Investing.com - Investing.com Australia
Immunovant stock hits 52-week high at 41.37 USD By Investing.com - Investing.com South Africa
Immunovant stock hits 52-week high at 41.37 USD By Investing.com - Investing.com Nigeria
Immunovant stock hits 52-week high at 41.37 USD - Investing.com
Immunovant stock hits 52-week high at 41.37 USD By Investing.com - Investing.com Canada
Immunovant stock hits 52-week high at 41.37 USD By Investing.com - Investing.com India
Immunovant stock hits 52-week high at 41.37 USD By Investing.com - Investing.com UK
The Manufacturers Life Insurance Company Cuts Stock Position in Immunovant, Inc. $IMVT - marketbeat.com
Immunovant, Inc. (IMVT) Stock Analysis: Assessing the 21% Potential Upside with Strong Analyst Confidence - DirectorsTalk Interviews
Immunovant, Inc. (NASDAQ:IMVT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
8.67%
0.07%
大文字化:
|
ボリューム (24 時間):